Tag Archives: Phase 3 clinical trial for vaccine being developed by China begins in Pakistan

The National Command and Operation Centre (NCOC) on Tuesday announced the launch of phase 3 clinical trials in Pakistan for a potential vaccine being developed by China’s CanSino Biologics for the novel coronavirus. Trials for phase 1 and 2 for the vaccine were held in China. Pakistan, under a public-private partnership between the National Institute of Health (NIH) and CanSino, …

Read More »